Image

Evaluation of SPH3127 in Patients With Mild-to-Moderate Ulcerative Colitis

Studying SPH3127 for mild-to-moderate ulcerative colitis patients.

Recruiting
18-70 years
All
Phase 2
  • Simplified description (AI rewritten)
  • Technical description (Original)

This study looks at a new drug called SPH3127 to help people with mild-to-moderate ulcerative colitis (UC), which is a condition causing inflammation in the colon. The trial will compare SPH3127 with a placebo (a pill with no active drug) over 8 weeks. Participants will take two tablets twice a day. You might be able to continue taking SPH3127 for 10 more months after the initial study period.

To join, you need to be 18 to 69 years old, have mild-to-moderate UC, and must not have any severe health issues. Certain medications and conditions can disqualify you. Women who are pregnant or breastfeeding cannot participate. Everyone must agree to use birth control methods if applicable.

  • The study lasts for about 8 weeks, with a chance for a longer treatment period.
  • You’ll need to take tablets twice a day and may have regular check-ups.
  • Potential risks include side effects from the medication, and you cannot take certain other drugs.

This study helps researchers learn more about the safety and effectiveness of SPH3127 for treating UC.

Print
Study details
    Ulcerative Colitis

NCT05019742

Shanghai Pharma Biotherapeutics USA Inc.

10 October 2024

Contact a study center
Step 1 Get in touch with the nearest study center
What happens next?
  • You can expect the study team to contact you via email or phone in the next few days.
  • Sign up as volunteer  to help accelerate the development of new treatments and to get notified about similar trials.

You are contacting

Investigator Avatar

Primary Contact

site

  Other languages supported:

FAQs

Learn more about clinical trials

What is a clinical trial?

A clinical trial is a study designed to test specific interventions or treatments' effectiveness and safety, paving the way for new, innovative healthcare solutions.

Why should I take part in a clinical trial?

Participating in a clinical trial provides early access to potentially effective treatments and directly contributes to the healthcare advancements that benefit us all.

How long does a clinical trial take place?

The duration of clinical trials varies. Some trials last weeks, some years, depending on the phase and intention of the trial.

Do I get compensated for taking part in clinical trials?

Compensation varies per trial. Some offer payment or reimbursement for time and travel, while others may not.

How safe are clinical trials?

Clinical trials follow strict ethical guidelines and protocols to safeguard participants' health. They are closely monitored and safety reviewed regularly.
Add a private note
  • abc Select a piece of text.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.